Current Assets
Prepaid & Other Current
Vertex Pharmaceuticals Prepaid & Other Current decreased by 15.5% to $720.8M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.1%, from $642.8M to $720.8M. Over 5 years (FY 2020 to FY 2025), Prepaid & Other Current shows an upward trend with a 22.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
Significant fluctuations may indicate changes in operational scale or timing of large service contracts and insurance premiums.
Detailed definition
This category encompasses payments made in advance for goods or services to be received in the future, along with other...
Peer comparison
Common across all industries; typically represents a small portion of total current assets.
Metric ID:
prepaid_and_other_current_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $498.76M | $457.83M | $545.8M | $491.5M | $549.5M | $726.9M | $553.5M | $468.7M | $476.9M | $540.2M | $623.7M | $511.1M | $575.4M | $449.2M | $665.7M | $642.8M | $652.3M | $709.4M | $853.3M | $720.8M |
| QoQ Change | — | -8.2% | +19.2% | -9.9% | +11.8% | +32.3% | -23.9% | -15.3% | +1.7% | +13.3% | +15.5% | -18.1% | +12.6% | -21.9% | +48.2% | -3.4% | +1.5% | +8.8% | +20.3% | -15.5% |
| YoY Change | — | — | — | — | +10.2% | +58.8% | +1.4% | -4.6% | -13.2% | -25.7% | +12.7% | +9.0% | +20.7% | -16.8% | +6.7% | +25.8% | +13.4% | +57.9% | +28.2% | +12.1% |
Range$449.2M – $853.3M
CAGR+8.1%
Avg YoY Growth+12.3%
Median YoY Growth+11.2%
Prepaid & Other Current at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's prepaid & other current?
- Vertex Pharmaceuticals (VRTX) reported prepaid & other current of $720.8M in Q1 2026.
- How has Vertex Pharmaceuticals's prepaid & other current changed year-over-year?
- Vertex Pharmaceuticals's prepaid & other current increased by 12.1% year-over-year, from $642.8M to $720.8M.
- What is the long-term trend for Vertex Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's prepaid & other current has grown at a 22.6% compound annual growth rate (CAGR), from $308.3M to $853.3M.
- What does prepaid & other current mean?
- Short-term assets representing payments made in advance or other miscellaneous current claims.